COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Covid Alert

Print ISSN:-2249-8176

Online ISSN:-2348-7682


Current Issue

Year 2020

Volume: 10 , Issue: 1

Article Access statistics

Viewed: 176

Emailed: 0

PDF Downloaded: 67

Panacea Journal of Medical Sciences

Perioperative management of malignant pheochromocytoma with coronary artery disease- A case report

Full Text PDF Share on Facebook Share on Twitter

Case Report

Author Details : Sambhunath Das*

Volume : 9, Issue : 3, Year : 2019

Article Page : 128-130

Suggest article by email


Presence of malignant pheochromocytoma tumor and coronary artery disease is extremely rare and carry high perioperative risk. The postoperative morbidity and mortality are increased by many folds. In the reference case, adrenal tumor had infiltrated to inferior vena cava (IVC), liver and right kidney. He had associated coronary artery disease. We describe the management of a patient with malignant tumor of adrenal gland undergoing surgical removal with all arrangements for coronary artery bypass grafting and intrathoracic extraction of tumor from IVC. It is a rare example of cardiac patient for non-cardiac surgery.

Keywords: Cardiac patient for non-cardiac surgery, Coronary artery disease, Malignant pheochromocytoma, Pheochromocytoma.

Doi : 10.18231/j.pjms.2019.027

How to cite : Das S, Perioperative management of malignant pheochromocytoma with coronary artery disease- A case report. Panacea J Med Sci 2019;9(3):128-130

Copyright © 2019 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (